Endobronchial Valves in Treatment of Persistent Air Leak: European Case-Series Study and Best Practice Recommendations - From an Expert Panel

被引:1
|
作者
Smesseim, Illaa [1 ]
Morin-Thibault, Louis-Vincent [2 ]
Herth, Felix J. F. [3 ,4 ]
Tonkin, James [5 ]
Shah, Pallav L. [5 ]
Slebos, Dirk-Jan [6 ]
Koster, David T. [6 ]
Dickhoff, Chris [7 ,8 ]
Daniels, Johannes Marlene Andreas [9 ]
Annema, Jouke [9 ]
Bonta, Peter [9 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Dept Thorac Oncol, Amsterdam, Netherlands
[2] CHU Quebec, Dept Pulm Dis, Quebec City, PQ, Canada
[3] Thoraxklin Heidelberg, Dept Pulm Dis, Heidelberg, Germany
[4] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[5] Chelsea & Westminster Hosp, Dept Pulm Dis, London, England
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands
[7] Amsterdam UMC Locat Vrije Univ Amsterdam, Dept Cardiothorac Surg, Amsterdam, Netherlands
[8] Canc Ctr Amsterdam, Canc Treatment & Qual Life, Amsterdam, Netherlands
[9] Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Pulmonol, Amsterdam, Netherlands
关键词
Persistent air leak; Pneumothorax; Endobronchial valve; Chest drainage; Pleurodesis; LUNG-VOLUME REDUCTION; SPONTANEOUS PNEUMOTHORAX; BRONCHOPLEURAL FISTULAS; PULMONARY RESECTION; TALC PLEURODESIS; MANAGEMENT; DRAINAGE;
D O I
10.1159/000539573
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Persistent air leak (PAL) is associated with prolonged hospitalization, high morbidity and increased treatment costs. Conservative treatment consists of observation, chest tube drainage, and pleurodesis. Guidelines recommend surgical evaluation if air leak does not respond after 3-5 days. One-way endobronchial valves (EBV) have been proposed as a treatment option for patients with PAL in which surgical treatment is not feasible, high risk or has failed. We aimed to provide a comprehensive overview of reported EBV use for PAL and issue best practice recommendations based on multicenter experience. Methods: We conducted a retrospective observational case-series study at four different European academic hospitals and provided best practice recommendations based on our experience. A systematic literature review was performed to summarize the current knowledge on EBV in PAL. Results: We enrolled 66 patients, male (66.7%), median age 59.5 years. The most common underlying lung disease was chronic obstructive pulmonary disease (39.4%) and lung cancer (33.3%). The median time between pneumothorax and valve placement was 24.5 days (interquartile range: 14.0-54.3). Air leak resolved in 40/66 patients (60.6%) within 30 days after EBV treatment. Concerning safety outcome, no procedure-related mortality was reported and complication rate was low (6.1%). Five patients (7.6%) died in the first 30 days after intervention. Conclusion: EBV placement is a treatment option in patients with PAL. In this multicenter case-series of high-risk patients not eligible for lung surgery, we show that EBV placement resulted in air leak resolution in 6 out of 10 patients with a low complication rate. Considering the minimally invasive nature of EBV to treat PAL as opposed to surgery, further research should investigate if EBV treatment should be expanded in low to intermediate risk PAL patients.
引用
收藏
页码:544 / 562
页数:19
相关论文
共 34 条
  • [1] Treatment of persistent air leak with endobronchial valves: a case report
    Cetinkaya, Erdogan
    Yasar, Zehra
    Acat, Murat
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2015, 63 (02): : 142 - 144
  • [2] Treatment of persistent air leak with endobronchial valves
    Van Hende, Fransien
    Carron, Kris
    ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (01) : 27 - 29
  • [3] Endoscopic one-way endobronchial valves in the treatment of persistent air leak with empyema: A Case Series
    Cusumano, Giacomo
    Fiorelli, Alfonso
    Bellofiore, Salvatore
    Lizzio, Carmelo Riscica
    Giarlotta, Rosalia
    Santini, Mario
    Terminella, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Endobronchial Valves in the Treatment of Persistent Air Leak, an Alternative to Surgery
    Cordovilla, Rosa
    Mateo Torracchi, Aldo
    Novoa, Nuria
    Jimenez, Marcelo
    Luis Aranda, Jose
    Varela, Gonzalo
    Barrueco, Miguel
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (01): : 10 - 15
  • [5] Treating Persistent Air Leak in COVID-19 with Spiration™ Endobronchial Valves: A Case Series
    Stone, B.
    Semaan, R.
    Dunlap, D. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [6] Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction
    Slebos, Dirk-Jan
    Shah, Pallav L.
    Herth, Felix J. F.
    Valipour, Arschang
    RESPIRATION, 2017, 93 (02) : 138 - 150
  • [7] Endobronchial Coils for Endoscopic Lung Volume Reduction: Best Practice Recommendations from an Expert Panel
    Slebos, Dirk-Jan
    ten Hacken, Nick H.
    Hetzel, Martin
    Herth, Felix J. F.
    Shah, Pallav L.
    RESPIRATION, 2018, 96 (01) : 1 - 11
  • [8] New pneumothorax complicating successful treatment of persistent air leak by endobronchial valves
    Yeung, Yiu Cheong
    Chan, Yu Hong
    Ho, Man Ying
    Chan, Ming Chiu
    Kwok, Hau Chung
    Yu, Wai Cho
    RESPIROLOGY CASE REPORTS, 2021, 9 (04):
  • [9] Endobronchial valve placement for treatment of a persistent air leak Case report
    Morrison, Morvern
    Marshall, Adam
    Giavedonni, Santiago
    Will, Malcolm
    MacKay, Tom
    Skwarski, Kris
    BREATHE, 2016, 12 (01) : 61 - 64
  • [10] ENDOBRONCHIAL VALVES FOR TREATMENT OF PERSISTENT AIR LEAK AFTER SECONDARY SPONTANEOUS PNEUMOTHORAX IN PATIENTS WITH CYSTIC FIBROSIS
    Podder, Shreya
    Benn, Bryan S.
    Franco, Rose A.
    Biller, Julie
    Kurman, Jonathan S.
    CHEST, 2022, 162 (04) : 2079A - 2080A